Document is current
Any future updates will be listed below
-
Authors
Moser, Bernhard
Hochreiter, Bernhard
Basílio, José
Gleitsmann, Viola
Panhuber, Anja
Pardo-Garcia, Alan
Hoesel, Bastian
Salzmann, Manuel
Resch, Ulrike
Noreen, Mamoona
Schmid, Johannes A. https://orcid.org/0000-0002-6586-3507
-
Funding
Funding for this research was provided by:
Austrian Science Fund (P23690, P27842, SFB-F54)
Österreichische Forschungsförderungsgesellschaft (Histology2.0)
- License Information
-
More Information
Article History
Received: 31 July 2020
Accepted: 4 January 2021
First Online: 18 January 2021
Ethics approval and consent to participate
: The ethics committee of the Medical University of Vienna and the Austrian Ministry of Sciences approved the use of the Hi-MYC transgenic mice (approval number: BMBWF-66.009/0035-V/3b/2019).
: All authors give consent for the publication of the manuscript in Molecular Cancer.
: The authors declare that they have no competing interest.
